This research determined the protective effect of supplementation of LBP, AE alone, and the combination against NASH, and further revealed that the combination therapy was more effective in ameliorating NASH by inhibiting DNL and activating AMPK/PPARα/PGC-1α pathway (Figure 6). Here, PPARA is linked to metabolic dysfunction-associated steatohepatitis.